Nebius Stock: Two Price-Target Cuts, a $38.7 Billion Backlog and a Profitability Gate Pushed to Late 2027

Wall Street's read on Nebius shifted on two fronts in a single day, and neither had much to do with demand. DA Davidson halved its price target on the AI-cloud provider from $250 to $125 while keeping a "Neutral" rating, with analyst Gil Luria pointing to delayed data centers and trimmed expectations for annualized revenue. Piper Sandler trimmed its own target to $148 from $185, also staying Neutral. Both moves land on the same fault line: the gap between contracts signed and capacity actually switched on.

That gap has a specific address. At the Vineland site, capacity availability hinges on power supply — the bottleneck disclosed a day earlier sits squarely between a signed contract and a recognized dollar. Nebius is targeting a $7 billion annualized revenue run rate by February 2027, and the analyst revisions effectively reset the yardstick investors will use to judge it. Strong growth still argues in the company's favor, provided the promised capacity arrives on schedule; slippage weighs on revenue for as long as ordered compute sits idle.

A Blockbuster Quarter With a Caveat

The top line offers plenty of momentum. Third-quarter 2026 revenue came in at $980.8 million, up 571% year over year on an unaudited basis, with the AI cloud accounting for nearly all of group sales. Adjusted EBITDA for the same period reached $465.8 million, a 47.5% margin.

Strip out the one-offs, though, and the picture gets more textured. Roughly $325 million of quarterly revenue came from one-time partnership proceeds involving limited capital outlay of Nebius's own. Extrapolating that margin only becomes defensible once recurring cloud revenue carries comparable earning power — a distinction that matters when the market is trying to decide what the run rate is actually worth.

The Backlog Is Real; the Delivery Schedule Is the Question

At the end of September 2026, remaining performance obligations stood at $38.7 billion, a figure that underpins the long-term revenue case as long as Nebius delivers and bills against those contracts. On newly signed deals, customer prepayments covered more than the entire associated investment, according to the company — a financing cushion for the build-out, so long as similar terms remain attainable for future capacity.

Management's own timeline adds a second gate. Nebius expects to reach pre-tax break-even in the fourth quarter of 2027, a perspective presented a day earlier. For anyone bullish on the growth story, that date is now a checkpoint — and any delay along the way has to be priced in.

Guidance at the Low End, Spending at the High End

The near-term outlook sharpened in a less comfortable direction. Nebius now expects 2026 revenue at the low end of its prior $3 billion to $3.4 billion range, while full-year revenue of $12 billion to $13 billion remains the target. Delays have pushed a portion of expected sales into the first half of 2027, the company said.

At the same time, the investment plan got bigger. Capital expenditure for 2027 was guided to $40 billion to $45 billion, an outlay that makes timely use of new capacity a load-bearing part of the economics. Reuters reported that the shares fell following the more cautious revenue outlook and the higher spending plan.

The tension is easy to state: high spending meeting revenue that has already slipped once. If capacity planning needs repeated recalibration, the build-out runs further ahead of the revenue path and the break-even target comes under harder scrutiny. The bull case requires the opposite — that the 571% growth rate holds as new capacity comes online, that the deferred revenue lands in the promised window, and that adjusted EBITDA of $465.8 million proves repeatable through the expansion.

The first half of 2027 is where that gets tested, since it is the period into which Nebius has shifted part of its previously expected sales. After that, the fourth-quarter 2027 pre-tax break-even serves as the next milestone. The question for investors is narrow: can the company convert contracted demand into billable capacity on time? Growth is not in doubt — the link between investment and revenue is.